{
  "zip": "20878",
  "sector": "",
  "fullTimeEmployees": 65,
  "longBusinessSummary": "MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally. Its transfection systems include MaxCyte STX, a scalable transfection system that uses flow electroporation technology for the engineering of cells for a range of applications; MaxCyte VLX, an instrument for large volume cell-engineering; and MaxCyte GT, a non-viral cell-engineering technology designed for clinical use. The company also provides single use sterile processing assemblies; and proprietary electroporation buffers; and ExPERT brand series of instruments and consumables, as well as insourcing services. In addition, it develops CARMA, a novel and proprietary technology for the development of non-viral, human messenger RNA-based, chimeric antigen receptor or T-cell receptor redirected immune cell therapies. The company licenses and sells its instruments and technology; and sells its products to drug developers and biopharmaceutical companies. It has a clinical and commercial license agreement with Allogene Therapeutics, Inc. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland.",
  "city": "Gaithersburg",
  "phone": "301 944 1700",
  "state": "MD",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.maxcyte.com",
  "maxAge": 1,
  "address1": "22 Firstfield Road",
  "fax": "301 944 1703",
  "industry": "",
  "address2": "Suite 110",
  "previousClose": 1.63,
  "regularMarketOpen": 6.1324,
  "twoHundredDayAverage": 2.4073927,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 6.1324,
  "navPrice": null,
  "averageDailyVolume10Day": 0,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.63,
  "fiftyDayAverage": 4.8081646,
  "trailingAnnualDividendRate": null,
  "open": 6.1324,
  "averageVolume10days": 0,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.985714,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 6.1324,
  "priceHint": 2,
  "currency": "USD",
  "regularMarketVolume": 2050,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": null,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 32,
  "priceToSalesTrailing12Months": null,
  "dayLow": 6.1324,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 2050,
  "fiftyTwoWeekHigh": 6.1324,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.63,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 6.1324,
  "exchange": "PNK",
  "shortName": "MAXCYTE INC",
  "longName": "MaxCyte, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "MAXC",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_4048262",
  "uuid": "4dbf1af7-c036-333a-a843-91b8fc14479e",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 3.891,
  "beta3Year": null,
  "profitMargins": -0.39299,
  "enterpriseToEbitda": -11.103,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": null,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0.52401,
  "netIncomeToCommon": -9486800,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.13008,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1593475200,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 60008947,
  "enterpriseValue": 93925256,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 6.1324,
  "logo_url": "https://logo.clearbit.com/maxcyte.com"
}